Rankings
▼
Calendar
BEAM Q2 2018 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$7M
Operating Income
-$10M
Net Income
-$10M
EPS (Diluted)
$-8.11
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$5M
Stock-Based Comp.
$603,500
← FY 2018
All Quarters
Q3 2018 →